Potential Monetary Value of Human Papillomavirus Vaccination on Human Papillomavirus-Related Cancers and Genital Warts in the United Kingdom

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.2271
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P5-S3.04 Continued Decline in Genital Warts 3 Years After Introduction of Quadrivalent Human Papillomavirus (HPV) Vaccination Program

Sexually Transmitted Infections
DermatologyInfectious Diseases
2011English

Vaccination Against Human Papillomavirus

CMAJ
Medicine
2007English

Vaccination Against Human Papillomavirus

CMAJ
Medicine
2007English

Isolation and Characterization of Human Papillomavirus Type 6-Specific T Cells Infiltrating Genital Warts.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1997English

Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015

MMWR. Morbidity and mortality weekly report
Health Information ManagementMutagenesisEpidemiologyHealthMedicineToxicology
2018English

The Healthcare Costs of Treating Human Papillomavirus-Related Cancers in Norway

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Cervical Cancer, Human Papillomavirus, and Vaccination

BMJ
2005English

P53 in Human Papillomavirus Associated Anogenital Cancers.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1995English

Overview of the Global Vaccination Against Human Papillomavirus

Pediatric pharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy